Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-02-24

FDA Approved: NORTRIPTYLINE HYDROCHLORIDE — Original Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved an original application for Nortriptyline Hydrochloride as a generic product by Zydus Lifesciences Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nortriptyline Hydrochloride (Nortriptyline hydrochloride)

Snippet

ORIG AP for NORTRIPTYLINE HYDROCHLORIDE (NORTRIPTYLINE HYDROCHLORIDE)